Home
Solutions
Patient Care
    Patient Experience
        A new technology for protecting the cardiac ostium of patients
        Interventional procedure for cardiac ostium replacement in a primipara
        Valgen Medtech DragonFly™ Protects the Cardiac Ostium of My Loved One
        中国医学科学院阜外医院潘湘斌教授携MitralStitch®二尖瓣瓣膜修复系统闪耀"一带一路"
    Patient Education on Diseases
        二尖瓣反流的超声心动图规范化检查建议
        Harpoon技术及临床研究解读
        TriClip临床研究解读
        经导管二尖瓣缘对缘修复技术最新临床证据解读
        三尖瓣治疗技术介绍
        世界心脏日 | 守护我们的心门：二尖瓣、三尖瓣漫谈
        二尖瓣 - 复杂的解剖
        经皮二尖瓣置换技术-路在何方
        案例分享 | 心脏里的“降落伞”坏了,微创不开胸完美修复！
        介入二尖瓣人工腱索修复 – DMR修复的未来
        文献解读｜JACC: 经导管二尖瓣修复美国经验：术者经验与手术结果的关系
        文献解读 | JACC：二尖瓣脱垂修复术后的远期随访结果
        文献解读 | 二尖瓣外科修复：病变部位对应的疗效比较
        二尖瓣反流微创介入修复器械未来可期
        中国老年瓣膜性心脏病注册：半数为二尖瓣反流，知晓率不足20%
Investment Information
    Periodic Reporting
About Valgen
    Company Overview
    News and Information
        DragonFly System Reinforces Global Clinical Evidence at CSI Frankfurt 2026
        Valgen Medtech's DragonFly System Receives EU CE Mark Approval for FMR, Achieving Full Indication Coverage for Mitral Regurgitation
        DragonFly System Obtains Commercial Approvals in Panama and Jordan
        First TEER Case with the DragonFly™ System in Vietnam
        Valgen Medtech Recognized as "Zhejiang Unicorn Enterprise" for 2026
        Breakthrough｜Valgen Medtech's Transcatheter Hypertrophic Cardiomyopathy (HCM) Ablation Technique Successfully Used for Exploratory Clinical Application in 10 Patients
        当西方遇见东方｜浙二王建安院士团队与全球结构性心脏病治疗专家就经导管瓣膜介入治疗展开深入技术交流
        Big News｜Valgen DragonFly™ Transcatheter Mitral Valve Repair System Granted Marketing Approval in China by the NMPA
        Valgen Medtech and Venus Medtech reached a consensus on signing a letter of intent for exclusive cooperation on strategic marketing to speed up the promotion of techniques for diagnosis and treatment of valvular heart disease (VHD) in China
        TCT 2023 | 德晋医疗DragonFly™，洞见二尖瓣修复治疗新趋势
        德晋医疗祝您双节快乐！
        铸瓣焕心 德道者晋｜德晋医疗荣获第六届中国医疗器械创新创业大赛医用高值耗材决赛二等奖
        浙大二院王建安教授团队攻克三尖瓣反流难题系列（DragonFly-T）｜TypeⅢB型、极重度原发性三尖瓣反流
        浙大二院王建安教授团队｜攻克三尖瓣反流难题系列（DragonFly-T）
        勇立潮头，奋楫争先 | 王建安教授团队应用DragonFly-T成功完成一例高难度三尖瓣病变缘对缘修复术
        DragonFly 首日亮相 CSI Frankfurt 2023
        德晋医疗祝您端午安康
        龙飞澳门 | 创新器械DragonFly™经导管二尖瓣缘对缘修复系统亮相MACI FORUM 2023
        德心应手 晋在掌握 I 第24届南方会德晋医疗二尖瓣缘对缘修复实践应用专场成功举办
        第24届南方会 | 艺启心境界 · 德诺专题会 学术盛宴邀您共聚
        EuroPCR 2023 | 中国创新器械DRAGONFLY—DMR确证性临床试验12个月随访结果首度公开
        每一双辛勤劳动的手，都在助力美好生活 | 德晋医疗祝您五一劳动节快乐
        浙二心脏瓣膜团队再次完成经导管三尖瓣缘对缘修复手术，彰显中国技术与器械实力
        CHINA VALVE（HANGZHOU）2023 | 细数德晋医疗“心动”时刻
        中国二尖瓣修复创新方案的崛起
        The project for the National Key R&D Program for the "14th Five-Year Plan" led by Valgen Medtech was officially approved
        北部战区总医院韩雅玲院士团队成功完成DragonFly™二尖瓣功能性反流临床研究本院首例入组
        “零缺陷”！德晋医疗两款三类产品通过生产许可检查
        携手共赢·共赴前程│德晋医疗杭州厂房乔迁庆典隆重举行
        Valgen Medtech Announces the Completion of its Round B Financing, in Which the Lead Investors Were DCP Capital and Sequoia Capital
    Careers
    Contact Us